|
“Big Beautiful Bill” Not so Beautiful for Healthcare
On May 22, 2025, the U.S. House of Representatives moved President Trump’s budget proposal forward, sending to the Senate a budget reconciliation bill (with a one-vote margin) – the One Big Beautiful Bill Act of 2025 – that renews expiring tax cuts and enacts new ones at a cost of almost $4 trillion. These costs would largely be paid for by cuts to other programs, including to federal healthcare programs, which cuts will have significant ramifications for the healthcare industry. This Health Capital Topics article reviews the current status of the budget bill and healthcare industry implications. (Read more...)
| |
Oregon Bans Corporate Control of Physicians
On June 9, 2025, Oregon’s governor signed into law the country’s strictest corporate practice of medicine (CPOM) prohibition. Senate Bill (SB) 951 will severely curtail the involvement of private equity firms and other corporations in the state’s medical practices. This Health Capital Topics reviews the bill and discusses the implications on the healthcare industry. (Read more...)
| |
Healthcare Spending Projected to Exceed $8.5 Trillion by 2033
On June 25, 2025, the Centers for Medicare & Medicaid Services (CMS) released its forecast on U.S. healthcare spending through 2033. The analysis, published in Health Affairs, estimated healthcare spending growth in 2024 and projected the growth into 2033. CMS found that overall healthcare spending growth has decreased slightly but is still elevated compared to pre-pandemic levels, and is expected to continue to moderately grow. This Health Capital Topics article examines the factors underlying the forecasts. (Read more...)
| |
Valuation of Anesthesiology Services: Reimbursement & Regulatory Environments
As discussed in the first installment of this three-part series on the valuation of anesthesiology services, despite the increasing demand for anesthesiology providers, Medicare reimbursement for anesthesiology has decreased over the past few years. Additionally, like other healthcare providers, anesthesiology clinicians face a range of federal and state legal and regulatory constraints that affect their formation, operation, procedural coding and billing, and transactions. Consequently, this second installment will review the reimbursement and regulatory landscapes in which these anesthesiology providers operate. (Read more...)
| |
Check out "Valuation of Freestanding Emergency Departments Part I of II" authored by HCC President, Todd A. Zigrang, MBA, MHA, FACHE, CVA, ASA, ABV, and, HCC Senior Vice President and General Counsel, Jessica Bailey-Wheaton, Esq., which was featured in the recent issue of The Value Examiner, published by the National Association of Certified Valuators and Analysts (NACVA) .
For more recently published material written by HCC, please visit www.healthcapital.com
Read Here
| |
"Role of Private Equity in Vascular Care," authored by HCC's Todd A. Zigrang and Jessica Bailey-Wheaton, as well as Bhagwan Satiani, MD, and Hiranya A. Rajasinghe, MD, was featured in the recent issue of the Journal of Vascular Surgery - Vascular Insights published by the Society of Vascular Surgery.
For more recently published material written by HCC, please visit www.healthcapital.com
Read Here
| |  |
|
